Per management, the primary competitive factors include company brand recognition, clinical research leadership, pricing and reimbursement.Factors to Bolster NevroNevro continues to benefit from sturdy international foothold, thereby driving overall performance.Per management, growth in Europe is anticipated to improve worldwide revenues in 2019.Further, robust prospects in the SCS market have been favoring the company over a considerable period of time.